Health State Classification Systems: How Comparable Are Our Cost-Effectiveness Ratios?

Abstract

Get full access to this article

View all access options for this article.

References

Fryback DG. A US valuation of the EQ-5D. Med Care. 2005;43:199-200.

Shaw JW , Johnson JA , Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203-220.

Gold MR , Patrick DL , Torrance GW , et al. Identifying and valuing outcomes. In: Gold MR , Siegel JE , Russell LB , Weinstein MC , eds. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press; 1996. p 82-134.

The EuroQoL Group . EuroQoL—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16: 199-208.

Feeny D , Furlong W , Torrance GW , et al. Multiattribute and single-attribute utility functions for the health utilities index Mark 3 system. Med Care. 2002;40:113-128.

Brazier J , Roberts J , Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21:271-292.

Tsuchiya A , Brazier J , Roberts J. Comparison of valuation methods used to generate the EQ-5D and the SF-6D value sets. J Health Econ. 2006;25:334-346.

Connor-Spady B , Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care. 2003;41:791-801.

Oostenbrink R , Moll HA , Essink-Bot ML. The EQ-5D and the Health Utilities Index for permanent sequelae after meningitis: a head-to-head comparison. J Clin Epidemiol. 2002;55:791-799.

10.

Marra CA , Woolcott JC , Kopec JA , et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med. 2005;60:1571-1582.

11.

O’Brien BJ , Spath M , Blackhouse G , Severens JL , Dorian P , Brazier J. A view from the bridge: agreement between the SF-6D utility algorithm and the Health Utilities Index. Health Econ. 2003;12:975-981.

12.

McDonough CM , Grove MR , Tosteson TD , Lurie JD , Hilibrand AS , Tosteson ANA . Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants. Qual Life Res. 2005;14: 1321-1332.

13.

Winkelmayer WC , Benner JS , Glynn RJ , et al. Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making. 2006;26:247-254.

14.

Avorn J , Benner J , Ford I , et al. Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial. Control Clin Trials 2002;23:757-773.

15.

Feeny D , Furlong W , Boyle M , Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7:490-502.

16.

Revicki DA , Leidy NK , Brennan-Diemer F , Sorensen S , Togias A. Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index. Chest. 1999;114:998-1007.